Genesis™ Low Temperature Rigid Sterilization Container System Validated for Modern Low-Temp Sterilization Practices
BD (Becton, Dickinson and Company , a leading global medical technology company, announced a new line of surgical instrument sterilization containers that are validated for the latest low-temperature sterilization processes.
The Genesis™ Low Temperature Rigid Sterilization Container System is validated for newer low-temperature sterilization processes and systems from market-leading sterilizer manufacturers, including the V-PRO® Low Temperature Sterilization Systems from STERIS and STERRAD® Systems from Advanced Sterilization Products (ASP). Low-temperature sterilization is a fast-growing trend in sterile processing and is used for instrumentation that cannot withstand the high-temperature and moisture present in traditional steam sterilization practices.
“Our new containers have the same trusted functionality that our customers in the sterile processing department have come to expect, but they have been validated for today’s latest low-temperature processes,” said Jim Leitl, worldwide vice president and general manager for Infection Prevention, V. Mueller and Interventional Specialties at BD. “We will continue to extend our leadership in sterilization containers and surgical instrumentation through innovations that positively impact both clinical and financial outcomes.”
The new containers have a visually differentiated set of orange components to quickly and easily differentiate them from Genesis containers intended for other sterilization processes. The line provides long-lasting protection and sterility maintenance for surgical instrumentation. Genesis containers are offered in a variety of sizes to help organize and secure instruments prior to surgery. Genesis containers also provide an environmentally friendly alternative to sterilization wrap.
The new Genesis Low Temperature Rigid Sterilization Container System will be commercially available later this spring, and they will be showcased in booth 620 at the IAHCSMM Annual Conference and Expo being held April 24-27 in San Antonio. To learn more, visit bd.com/LowTempGenesis .
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com .